Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAYtm ...
Optomap green-channel lesion intensity correlates with ultrasonographic choroidal tumor thickness, according to research.